Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Click Reactions in Medicinal ChemistryDamien BoscJournal of Medicinal Chemistry|September 24, 2009
Discovery of a new class of protein farnesyltransferase inhibitors in the arylthiophene seriesSébastien Lethu, Maryon Ginisty, Damien Bosc, et al.Future Medicinal Chemistry|February 16, 2016
Kinetic target-guided synthesis in drug discovery and chemical biology: a comprehensive facts and figures surveyDamien Bosc, Jouda Jakhlal, Benoit Deprez, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 12, 2012
New protein farnesyltransferase inhibitors in the 3-arylthiophene 2-carboxylic acid series: diversification of the aryl moiety by solid-phase synthesisSébastien Lethu, Damien Bosc, Elisabeth Mouray, et al.Journal of Medicinal Chemistry|December 11, 2019
Kinetic Target-Guided Synthesis: Reaching the Age of MaturityDamien Bosc, Virgyl Camberlein, Ronan Gealageas, et al.The Journal of Organic Chemistry|February 24, 2017
Comparative Study of the Synthesis and Structural and Physicochemical Properties of Diketopiperazines vs Aza-diketopiperazinesPierre Regenass, Damien Bosc, Stéphanie Riché, et al.Molecules (Basel, Switzerland)|October 13, 2021
Molecular Design in Practice: A Review of Selected Projects in a French Research Institute That Illustrates the Link between Chemical Biology and Medicinal ChemistryBenoit Deprez, Damien Bosc, Julie Charton, et al.Bioorganic & Medicinal Chemistry|May 17, 2015
Development of fluorescent peptide substrates and assays for the key autophagy-initiating cysteine protease enzyme, ATG4BLubomir Vezenkov, Nicolette S Honson, Nag S Kumar, et al.European Journal of Medicinal Chemistry|January 18, 2016
Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitorsDamien Bosc, Elisabeth Mouray, Sandrine Cojean, et al.Autophagy|October 29, 2015
Precision autophagy: Will the next wave of selective autophagy markers and specific autophagy inhibitors feed clinical pipelines?Chandra B Lebovitz, Lindsay DeVorkin, Damien Bosc, et al.Pageof 2